Norepinephrine responses in rat renal and femoral veins are reinforced by vasoconstrictor prostanoids

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Uridine adenosine tetraphosphate-induced contraction is increased in renal but not pulmonary arteries from DOCA-salt hypertensive rats

Matsumoto T, Tostes RC, Webb RC. Uridine adenosine tetraphosphate-induced contraction is increased in renal but not pulmonary arteries from DOCA-salt hypertensive rats. Am J Physiol Heart Circ Physiol 301: H409-H417, 2011. First published May 6, 2011; doi:10.1152/ajpheart.00084.2011.-Uridine adenosine tetraphosphate (Up(4)A) was reported as a novel endothelium-derived contracting factor. Up(4)A contains both purine and pyrimidine moieties, which activate purinergic (P2)X and P2Y receptors. However, alterations in the vasoconstrictor responses to Up(4)A in hypertensive states remain unclear. The present study examined the effects of Up(4)A on contraction of isolated renal arteries (RA) and pulmonary arteries (PA) from DOCA-salt rats using isometric tension recording. RA from DOCA-salt rats exhibited increased contraction to Up(4)A versus arteries from control uninephrectomized rats in the absence and presence of N(G)-nitro-L-arginine (nitric oxide synthase inhibitor). On the other hand, the Up(4)A-induced contraction in PA was similar between the two groups. Up(4)A-induced contraction was inhibited by suramin (nonselective P2 antagonist) but not by diinosine pentaphosphate pentasodium salt hydrate (Ip5I; P2X(1) antagonist) in RA from both groups. Furthermore, 2-thiouridine 5`-triphosphate tetrasodium salt (2-Thio-UTP; P2Y(2) agonist)-, uridine-5`-(gamma-thio)-triphosphate trisodium salt (UTP gamma S; P2Y(2)/P2Y(4) agonist)-, and 5-iodouridine-5`-O-diphosphate trisodium salt (MRS 2693; P2Y(6) agonist)-induced contractions were all increased in RA from DOCA-salt rats. Protein expression of P2Y(2)-, P2Y(4)-, and P2Y(6) receptors in RA was similar between the two groups. In DOCA-salt RA, the enhanced Up(4)A-induced contraction was reduced by PD98059, an ERK pathway inhibitor, and Up(4)Astimulated ERK activation was increased. These data are the first to indicate that Up(4)A-induced contraction is enhanced in RA from DOCA-salt rats. Enhanced P2Y receptor signaling and activation of the ERK pathway together represent a likely mechanism mediating the enhanced Up(4)A-induced contraction. Up(4)A might be of relevance in the pathophysiology of vascular tone regulation and renal dysfunction in arterial hypertension.

Preparazione mediante elettrofilatura di membrane polimeriche composite per scopi catalitici.

Vi è un crescente interesse verso lo studio di materiali compositi nanostrutturati. Tra questi risultano di particolare interesse le membrane polimeriche composite. Questi materiali presentano proprietà uniche, sono già largamente utilizzate in ambito bio-medicale, industriale e in molti processi di separazione di effluenti liquidi e gassosi. Un’altra applicazione di grande interesse è l’utilizzo di queste membrane come catalizzatori, in particolare per lo sviluppo di sistemi in flusso. Le membrane polimeriche composite per scopi catalitici vengono prodotte inserendo una fase attiva inorganica nella matrice polimerica; una delle tecniche di produzione è l’elettrofilatura. Questa tecnica permette di ottenere fibre polimeriche di diametro sub-micrometrico, sfruttando l’azione di un intenso campo elettrico. In questo lavoro è stata studiata la preparazione di membrane catalitiche aventi come matrice polimerica il Nylon 6,6 e il polietileneossido (PEO), contenenti come fase attiva Au e Pd. La produzione di queste membrane viene studiata per una possibile applicazione in sistemi in flusso per l’ossidazione selettiva del 5-idrossimetilfurfurale (5-HMF) ad acido 2,5 furan-dicarbossilico (FDCA). Questa reazione è molto importante, in quanto consente di ottenere monomeri plastici di origine vegetale, come può essere l’FDCA.

Strategie terapeutiche nel trattamento riabilitativo del soggetto affetto da Malattia di Parkinson: Scoping Review

Background: La Malattia di Parkinson è una malattia neurodegenerativa che dà disturbi del movimento tipici: tremore a riposo, ipocinesia o bradicinesia, rigidità e instabilità posturale; inoltre, include anche disturbi non motori quali: ansia, depressione, disturbi del sonno, disfagia, disartria e deterioramento cognitivo. L’insieme dei sintomi motori e non motori influenza la quotidianità del paziente, riduce la partecipazione e la qualità di vita in tutte le fasi della malattia. La riabilitazione motoria può aiutare a mitigare gli effetti dei sintomi motori e migliorare la qualità della vita del soggetto con PD[6,7], ma non esiste un protocollo univoco per il trattamento di questa malattia. Obiettivo: l’obiettivo di questa Scoping Review è di individuare strategie terapeutiche alternative al trattamento convenzionale nel percorso riabilitativo del paziente affetto da Malattia di Parkinson. Disegno dello studio: sono stati presi in considerazione studi pubblicati tra il 2020 e il 2022 su diverse attività non tradizionali proposte a pazienti con Parkinson. Le banche dati utilizzate sono PubMed, PEDro e Cochrane Library. Sono stati posti come criteri di inclusione: soggetti esclusivamente con Malattia di Parkinson di età > 18 anni e articoli in lingua inglese. Sono stati inclusi quindi Review, RCT e articoli di giornali che soddisfacessero la checklist della PRISMA Extension per le Scoping Review. Risultati: al termine della selezione, sono stati inclusi 6 studi che facevano riferimento ad attività come il ballo, l’arrampicata sportiva, l’esercizio in acqua, lo Yoga, il Nordic Walking e la teleriabilitazione nel PD. Conclusioni: la letteratura analizzata fornisce buoni risultati legati alle attività per il trattamento di sintomi motori e non motori del soggetto con PD. Tuttavia, gli studi hanno riportato la necessità di eseguire ulteriori prove per una conferma dell’efficacia statisticamente significativa sui disturbi del PD, con gruppi di pazienti più ampi.

Polymerization kinetics and reactivity of alternative initiators systems for use in light-activated dental resins

Objectives. The purpose of this study was to evaluate the reactivity and polymerization kinetics behavior of a model dental adhesive resin with water-soluble initiator systems. Methods. A monomer blend based on Bis-GMA, TEGDMA and HEMA was used as a model dental adhesive resin, which was polymerized using a thioxanthone type (QTX) as a photoinitiator. Binary and ternary photoinitiator systems were formulated using 1 mol% of each initiator. The co-initiators used in this study were ethyl 4-dimethylaminobenzoate (EDAB), diphenyliodonium hexafluorophosphate (DPIHFP), 1,3-diethyl-2-thiobarbituric acid (BARB), p-toluenesulfinic acid and sodium salt hydrate (SULF). Absorption spectra of the initiators were measured using a UV-Vis spectrophotometer, and the photon absorption energy (PAE) was calculated. The binary system camphorquinone (CQ)/amine was used as a reference group (control). Twelve groups were tested in triplicate. Fourier-transform infrared spectroscopy (FTIR) was used to investigate the polymerization reaction during the photoactivation period to obtain the degree of conversion (DC) and maximum polymerization rate (R-p(max)) profile of the model resin. Results. In the analyzed absorption profiles, the absorption spectrum of QTX is almost entirely localized in the UV region, whereas that of CQ is in the visible range. With respect to binary systems, CQ + EDAB exhibited higher DC and R-p(max) values. In formulations that contained ternary initiator systems, the group CQ + QTX + EDAB was the only one of the investigated experimental groups that exhibited an R-p(max) value greater than that of CQ + EDAB. The groups QTX + EDAB + DPIHFP and QTX + DPIHFP + SULF exhibited values similar to those of CQ + EDAB with respect to the final DC; however, they also exhibited lower reactivity. Significance. Water-soluble initiator systems should be considered as alternatives to the widely used CQ/amine system in dentin adhesive formulations. (C) 2012 Academy of Dental Materials. Published by Elsevier Ltd. All rights reserved.

GLUTAMATERGIC MECHANISMS OF THE DORSAL PERIAQUEDUCTAL GRAY MATTER MODULATE THE EXPRESSION OF CONDITIONED FREEZING AND FEAR-POTENTIATED STARTLE

It is well known that excitatory amino acids induce unconditioned fear responses when locally injected into the dorsal periaqueductal gray matter (dPAG). However, there are only few studies about the involvement of excitatory amino acids mediation in dPAG in the expression of conditioned fear. The present series of experiments evaluates the participation of AMPA/Kainate and NMDA glutamatergic receptors of dPAG in the expression of conditioned fear, assessed by the fear-potentiated startle (FPS) and conditioned freezing responses. Wistar rats were subjected to fear conditioning to light. Twenty-four hours later, they received intra-dPAG injections of kainic acid or NMDA (AMPA/Kainate and NMDA agonists) and 1,2,3,4-Tetrahydro-6-nitro-2, 3-dioxo-benzo[f]quinoxaline-7-sulfonamide disodium salt hydrate (NBQX) or D(-)-2-Amino-7-phosphonoheptanoic acid (APT) (AMPA/Kainate and NMDA antagonists) and were submitted to the FPS test. Conditioned freezing response was simultaneously measured. Effects of drug treatment on motor activity were evaluated in the open-field test. Intra-dPAG injections of glutamatergic agonists enhanced conditioned freezing and promoted pro-aversive effects in the FPS. Lower doses of the agonists had no effect or enhanced FPS whereas higher doses disrupted FPS, indicating a non-monotonic relationship between fear and FPS. The antagonist NBQX had no significant effects while AP7 decreased conditioned freezing but did not affect FPS. Both antagonists reduced the effects of the agonists. The obtained results cannot be attributed to motor deficits. The results suggest an important role of the AMPA/Kainate and NMDA mechanisms of the dPAG in the expression of conditioned freezing and FPS. (C) 2012 IBRO. Published by Elsevier Ltd. All rights reserved.

"Lesion journey" nell'idrosadenite suppurativa: correlazione clinica e ultrasonografica

Introduzione: L'idrosadenite suppurativa (HS) è una malattia immuno-mediata che colpisce i follicoli piliferi situati principalmente nelle aree ricche di ghiandole apocrine. Materiali e metodi: È stato condotto uno studio osservazionale prospettico monocentrico finalizzato a correlare i parametri clinici ed ecografici con: l'evoluzione delle lesioni, la probabilità di riacutizzazione o di andare incontro ad un trattamento chirurgico/laser-CO2. Risultati: Sono stati reclutati sessantuno pazienti con un'età media pari a 29,5 ± 7,5 anni che presentavano un numero basale di 127 noduli infiammatori, 43 ascessi e 62 fistole. Dopo un tempo medio di 77,9 settimane, rispettivamente il 40%, 14%, 8% di noduli, ascessi e fistole erano guariti, il 5%, 30%, 29% persistevano privi di infiammazione, il 47%, 33%, 63 % presentava uno stato infiammatorio, e l'8% e il 23% dei noduli e degli ascessi erano evoluti in fistole. Sono stati registrati 137 episodi di flare nelle lesioni acute (noduli + ascessi) e 54 nelle lesioni croniche (fistole), mentre il numero di interventi procedurali è stato rispettivamente pari a 59 e 50. I fattori predittivi associati ad un'evoluzione sfavorevole (stato infiammatorio o cronicizzazione) per ascessi e noduli sono stati: evidenza ecografica di frammenti piliferi intralesionali, elevato segnale Power Doppler (PD) ed edema all'ecografia, profondità della localizzazione ed interessamento genitale; i predittori associati alle fistole sono stati: profondità della localizzazione, edema e dimensioni della lesione. La probabilità che una lesione acuta venisse sottoposta ad un intervento procedurale è stata correlata a: età, presenza di frammenti piliferi, segnale PD, edema e profondità della localizzazione; per le fistole l'unico predittore indipendente è stato la dimensione. I predittori di riacutizzazione della patologia per ascessi e noduli sono stati: giovane età all'esordio, segnale PD, evidenza ecografica di frammenti follicolari, profondità della localizzazione e dimensioni; per le fistole i predittori sono stati: localizzazione ascellare, profondità della localizzazione, edema e dimensione.

The Analgesic Effect Of Dipyrone In Peripheral Tissue Involves Two Different Mechanisms: Neuronal K(atp) Channel Opening And Cb(1) Receptor Activation.

Dipyrone (metamizole) is an analgesic pro-drug used to control moderate pain. It is metabolized in two major bioactive metabolites: 4-methylaminoantipyrine (4-MAA) and 4-aminoantipyrine (4-AA). The aim of this study was to investigate the participation of peripheral CB1 and CB2 cannabinoid receptors activation in the anti-hyperalgesic effect of dipyrone, 4-MAA or 4-AA. PGE2 (100ng/50µL/paw) was locally administered in the hindpaw of male Wistar rats, and the mechanical nociceptive threshold was quantified by electronic von Frey test, before and 3h after its injection. Dipyrone, 4-MAA or 4-AA was administered 30min before the von Frey test. The selective CB1 receptor antagonist AM251, CB2 receptor antagonist AM630, cGMP inhibitor ODQ or KATP channel blocker glibenclamide were administered 30min before dipyrone, 4-MAA or 4-AA. The antisense-ODN against CB1 receptor expression was intrathecally administered once a day during four consecutive days. PGE2-induced mechanical hyperalgesia was inhibited by dipyrone, 4-MAA, and 4-AA in a dose-response manner. AM251 or ODN anti-sense against neuronal CB1 receptor, but not AM630, reversed the anti-hyperalgesic effect mediated by 4-AA, but not by dipyrone or 4-MAA. On the other hand, the anti-hyperalgesic effect of dipyrone or 4-MAA was reversed by glibenclamide or ODQ. These results suggest that the activation of neuronal CB1, but not CB2 receptor, in peripheral tissue is involved in the anti-hyperalgesic effect of 4-aminoantipyrine. In addition, 4-methylaminoantipyrine mediates the anti-hyperalgesic effect by cGMP activation and KATP opening.

Synthesis and electrochemical properties of vanadyl phosphate di-hydrate/polyaniline derivatives hybrid films

Vanadyl phosphate and its hybrid compounds have proven to undergo electrochemical intercalation and de-intercalation of lithium ions, which enables its use as cathode material for Li ion rechargeable batteries. In this context, vanadyl phosphate di-hydrate/polyaniline derivatives hybrid films were synthesized via the exfoliation and reconstruction approach in order to evaluate their potential use as cathode in ion lithium batteries. X-ray diffraction patterns indicate that the lamellar structure of the inorganic matrix is maintained, consistent with the topotactic process. In the scanning electron micrographs, hybrid films exhibit rough surface consisting of warped and cracked crystallites, quite different from vanadyl phosphate di-hydrate square platelets crystallites. Electrochemical evaluation using cyclic voltammetry and charge-discharge galvanostatic techniques shows small differences between the charge and the discharge curves, indicating an irreversibility of the hybrid systems. (C) 2009 Elsevier B.V. All rights reserved.

Salt and ionic cocrystalline forms of amides: protonation of carbamazepine in aqueous media

The products of reactions of the pharmaceutical amide carbamazepine (CBZ) with strong acids under aqueous conditions were investigated by both powder and single crystal X-ray diffraction. Despite previous claims to the contrary, it was found that salt forms with CBZ protonated at the amide O atom could be isolated from reactions with both HCl and HBr. These forms include the newly identified hydrate phase [CBZ(H)][Cl]·H O. Reactions with other mineral acids (HI and HBF ) gave ionic cocrystalline (ICC) forms (CBZ· [acridinium][I ]·2.5I and CBZ·[H O ] [BF ] ·H O) as well as the salt form CBZ·[CBZ(H)][BF ]·0.5H O. Reaction 2 4 3 2 5 2 0.25 4 0.25 2 4 2 of CBZ with a series of sulfonic acids also gave salt forms, namely, [CBZ(H)][O SC H ], [CBZ(H)][O SC H (OH)]· 3 6 5 3 6 4 0.5H O, [CBZ(H)] [O SCH CH SO ], and [CBZ(H)][O SC H (OH) (COOH)]·H O. CBZ and protonated CBZ(H) 2 2 3 2 2 3 3 6 3 2 moieties can be differentiated in the solid state both by changes to molecular geometry and by differing packing preferences

1,3-dipolar cycloaddition of CS2 to the coordinated azide in the cyclopalladated [Pd(bzan)(mu-N-3)](2). Crystal and molecular structure of di(mu-N,S-1,2,3,4-thiatriazole-5-thiolate)bis[(benzylideneaniline-C-2,N)palladium(II)]

The compound [Pd(bzan)(mu -N-3)](2) 1, bzan = benzylideneaniline, was prepared from [Pd(bzan) (mu -OOCCH3)](2) by an anion exchange reaction. The 1,3-dipolar cycloaddition of carbon disulfide to the bridged coordinated azide in the cyclometallated compound I was investigated. The species resulting from this reaction, di(mu -N,S-1,2,3,4-thiatriazol-5-thiolate)bis[(benzylideneaniline)palladium(II)] 2, was characterized by IR spectroscopy and X-ray diffraction. The compound 2 is a dimer containing two [Pd(benzylideneaniline)] moieties connected by two vicinal bridging N,S-1,2,3,4-thiatriazole-5-thiolate anions in a square-planar coordination geometry for the palladium atoms.

Cycloaddition reaction of the azido-bridged cyclometallated complex [Pd(dmba)N-3](2) with CS2. Crystal and molecular structure of DI(mu, N,S-1,2,3,4-thiatriazole-5-thiolate) bis[(N,N-dimethylbenzyl-amine-C-2,N)palladium(II)]

The 1,3-dipolar cycloaddition of carbon disulfide to the coordinated azide in the cyclometallated compound [Pd(dmba)(N-3)](2) (1), dmba = N,N-dimethylbenzylamine, was investigated. The compound obtained di(mu, N,S-1,2,3,4-thiatriazole-5-thiolate)-bis[(N,N-dimethylbenzylamine-C-2,N)palladium(II)] (2), was characterized by IR spectroscopy and X-ray diffraction. Complex (2) is dimeric with the two [Pd(N,N-dimethylbenzylamine)] moieties being connected by the two vicinal bridging N,S-1,2,3,4-thiatriazole-5-thiolate anions in a square-planar coordination for the palladium atoms.

SYNTHESIS AND CRYSTAL-STRUCTURE OF THE NOVEL CYCLOPALLADATED COMPLEX DI(MU,N-S-ETA(2)-QUINOLINE-2-THIOLATE)-BIS[(N,N-DIMETHYLBENZYLAMINE-C(2),N) PALLADIUM(II)]

The compound di(mu,N-Seta2-2-quinoline-2-thiolate)-bis[(N,N-dimethylbenzylamine-C2,N)palladium(II)] was synthesized and studied by IR, NMR and X-ray diffraction: monoclinic, a = 20.138(3), b = 10.831(1), c = 14.973(2) angstrom, beta = 98.04(1)-degrees, Z = 4, space group P2(1)/c, R = 0.032. The compound is dimeric with the two [Pd(N,N-dimethylbenzylamine)]moieties being connected by the two vicinal bridging eta2-N,S-quinoline-2-thiolate anions in a square-planar coordination geometry for the palladium atoms.

Crystal structure of di-mu(N,S)-thiocyanato-bis[(N-benzylideneaniline-C-2,N)palladium(II)], [Pd(C6H4CH=NC6H5)(mu-SCN)](2)

C28H20N4Pd2S2, monoclinic, P12(1)/c1 (No. 14), a = 11.325(1) Angstrom, b = 13.530(1) Angstrom, c = 17.925(1) Angstrom, beta = 106.23(1)degrees, V = 2637.1 Angstrom(3), Z = 4, R-gt(F) = 0.052, wR(ref)(F-2) = 0.129, T = 293 K.

Crystal structure of di-μ(N,S)-thiocyanato-bis[(N-benzylideneaniline-C 2,N)palladium(II)], [Pd(C6H4CH=NC 6H5)(μ-SCN)]2

C28H20N4Pd2S2, monoclinic, P121/c1 (No. 14), a = 11.325(1) Å, b = 13.530(1) Å, c = 17.925(1) Å, β = 106.23(1)°, V = 2637.1 Å 3, Z = 4, Rgt(F) = 0.052, wRref(F2) = 0.129, T = 293 K. © by Oldenbourg Wissenschaftsverlag.